Lungnet

Multi-Centre Trials Network

The Australian Lung Foundation’s Multi-centre Clinical Trials Network (ALF MCTN) is an established administration service, available to both Clinical Trial Sponsors and Contract Research Organisations (CROs). The service can provide access to both a large-scale Investigator network and a patient database. The ALF MCTN is supported by an efficient and timely ethics submission process, underpinned by an established subject recruitment campaign management system.

The ALF MCTN was formed to support both Local and International studies. The service does not compete with Institutions that undertake clinical trials, but aims to enhance the recruitment base so that, collectively, recruitment targets and tight study timelines can be met.

On an International basis, Australia and New Zealand are viewed as “countries of choice” for conducting clinical research, both in terms of the logistics involved, as well as the excellent standard of clinical conduct that exists in this country, which in turn boosts confidence with the scientific conclusions reached.

The MCTN business returns any financial surplus arising to the ALF, thus assisting the Foundation to fulfil its role as the peak non-government respiratory organisation and a key agent of change in Australia, facilitating the understanding, management and relief of lung disease.

 Multi-Centre Trials Network Capability Statement 992.30 Kb

Note: Copies of this document can also be ordered through the ALF

Phone: (07) 3357 6388 or

Email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Content updated March 10, 2008